These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 32082273)
21. [BCG vaccines for the prevention of tuberculosis in the world]. Hashimoto T Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301 [TBL] [Abstract][Full Text] [Related]
22. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940 [TBL] [Abstract][Full Text] [Related]
23. Recent advances in the development of vaccines for tuberculosis. Ahsan MJ Ther Adv Vaccines; 2015 May; 3(3):66-75. PubMed ID: 26288734 [TBL] [Abstract][Full Text] [Related]
24. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Martín C Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403 [TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting. Penn-Nicholson A; Geldenhuys H; Burny W; van der Most R; Day CL; Jongert E; Moris P; Hatherill M; Ofori-Anyinam O; Hanekom W; ; Bollaerts A; Demoitie MA; Kany Luabeya AK; De Ruymaeker E; Tameris M; Lapierre D; Scriba TJ Vaccine; 2015 Jul; 33(32):4025-34. PubMed ID: 26072017 [TBL] [Abstract][Full Text] [Related]
26. [New vaccines against tuberculosis]. Kaufmann SHE Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):56-64. PubMed ID: 31784764 [TBL] [Abstract][Full Text] [Related]
27. "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report. Boggiano C; Eichelberg K; Ramachandra L; Shea J; Ramakrishnan L; Behar S; Ernst JD; Porcelli SA; Maeurer M; Kornfeld H Vaccine; 2017 Jun; 35(27):3433-3440. PubMed ID: 28476627 [TBL] [Abstract][Full Text] [Related]
28. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
29. Tuberculosis vaccine: A journey from BCG to present. Fatima S; Kumari A; Das G; Dwivedi VP Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522 [TBL] [Abstract][Full Text] [Related]
34. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application. Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A Front Immunol; 2018; 9():308. PubMed ID: 29535713 [TBL] [Abstract][Full Text] [Related]
35. Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Cohn DL Am J Med Sci; 1997 Jun; 313(6):372-6. PubMed ID: 9186153 [TBL] [Abstract][Full Text] [Related]
36. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
37. Vaccine strategies for the Sharan R; Kaushal D NPJ Vaccines; 2020; 5():95. PubMed ID: 33083030 [TBL] [Abstract][Full Text] [Related]